JPMorgan Upgrades Integra LifeSciences (IART) to Overweight
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Price: $17.97 +1.07%
Rating Summary:
9 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 15
Rating Summary:
9 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 15
Join SI Premium – FREE
JPMorgan upgraded Integra LifeSciences (NASDAQ: IART) from Neutral to Overweight with a price target of $80.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $64.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences Announces Key Executive Appointments
- Berenberg Upgrades Liontrust Asset Management (LIO:LN) to Buy
- Jefferies Upgrades Xylem (XYL) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
